361 related articles for article (PubMed ID: 10435397)
21. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways.
Sakai K; Gao XM; Hashimoto T; Tamminga CA
Synapse; 2001 Feb; 39(2):152-60. PubMed ID: 11180502
[TBL] [Abstract][Full Text] [Related]
22. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Li M; Sun T; Zhang C; Hu G
Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
[TBL] [Abstract][Full Text] [Related]
23. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.
Heidbreder CA; Foxton R; Cilia J; Hughes ZA; Shah AJ; Atkins A; Hunter AJ; Hagan JJ; Jones DN
Psychopharmacology (Berl); 2001 Jul; 156(2-3):338-51. PubMed ID: 11549234
[TBL] [Abstract][Full Text] [Related]
24. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
26. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
[TBL] [Abstract][Full Text] [Related]
27. Effects of atypical antipsychotic drugs vs. haloperidol on expression of heat shock protein in the discrete brain regions of phencyclidine-treated rats.
Nakahara T; Kuroki T; Hondo H; Tsutsumi T; Fukuda K; Yao H; Uchimura H
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):193-7. PubMed ID: 10581414
[TBL] [Abstract][Full Text] [Related]
28. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
Porter JH; McCallum SE; Varvel SA; Vann RE
Psychopharmacology (Berl); 2000 Feb; 148(3):224-33. PubMed ID: 10755735
[TBL] [Abstract][Full Text] [Related]
29. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
30. Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain.
Nakahara T; Kuroki T; Hashimoto K; Hondo H; Tsutsumi T; Motomura K; Ueki H; Hirano M; Uchimura H
Neuroreport; 2000 Feb; 11(3):551-5. PubMed ID: 10718313
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
Stockton ME; Rasmussen K
Psychopharmacology (Berl); 1996 Mar; 124(1-2):50-6. PubMed ID: 8935800
[TBL] [Abstract][Full Text] [Related]
32. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.
Potvin S; Stip E; Roy JY
Int Clin Psychopharmacol; 2003 May; 18(3):121-32. PubMed ID: 12702890
[TBL] [Abstract][Full Text] [Related]
33. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
34. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
[TBL] [Abstract][Full Text] [Related]
35. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Pillai A; Parikh V; Terry AV; Mahadik SP
J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
[TBL] [Abstract][Full Text] [Related]
36. Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain.
Depoortere R; Perrault G; Sanger DJ
Behav Pharmacol; 1997 Aug; 8(4):364-72. PubMed ID: 9832995
[TBL] [Abstract][Full Text] [Related]
37. Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa).
Trevitt JT; Carlson BB; Salamone JD
Psychopharmacology (Berl); 1999 Aug; 145(3):309-16. PubMed ID: 10494580
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
[TBL] [Abstract][Full Text] [Related]
39. Glucose intolerance with atypical antipsychotics.
Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
[TBL] [Abstract][Full Text] [Related]
40. The relationship of pharmacology to side effects.
Casey DE
J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
